DOSSIER · 13F Holders · Q2 2026

Ascendis Pharma AS

274 institutions still hold Ascendis Pharma AS as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP K08588103·274 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$13.7B
visible holders
Holders
274
filers reporting
Concentration
20.00%
RA CAPITAL MANAGEMENT, L.P. #1
top holder share
AI Holders Summary · Q2 2026

274 institutions reported Ascendis Pharma AS in Q2 2026. RA CAPITAL MANAGEMENT, L.P. leads at 20.0% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
RA CAPITAL MANAGEMENT, L.P.
CIK 0001346824
$2.7B10.3M23.83%Q2 2026
02
T. Rowe Price Investment Management, Inc.
CIK 0001897612
$1.4B6.2M0.97%Q1 2026
03
Avoro Capital Advisors LLC
CIK 0001633313
$1.4B5.1M12.24%Q2 2026
04
WESTFIELD CAPITAL MANAGEMENT CO LP
CIK 0001177719
$1.3B4.8M4.18%Q2 2026
05
Jupiter Topco LLC
CIK 0002146052
$973M3.6M0.40%Q2 2026
06
FMR LLC
CIK 0000315066
$946M3.5M0.04%Q2 2026
07
Artisan Partners Limited Partnership
CIK 0001466153
$703M2.6M1.11%Q2 2026
08
BlackRock, Inc.
CIK 0002012383
$590M2.2M0.01%Q2 2026
09
Capital International Investors
CIK 0001562230
$530M2.0M0.11%Q2 2026
10
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
CIK 0000912938
$500M1.9M0.16%Q2 2026
11
FRANKLIN RESOURCES INC
CIK 0000038777
$497M1.9M0.11%Q2 2026
12
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$413M1.5M0.07%Q2 2026
13
AMERICAN CENTURY COMPANIES INC
CIK 0000748054
$374M1.4M0.17%Q2 2026
14
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$350M1.5M0.04%Q1 2026
15
Capital World Investors
CIK 0001422849
$242M906K0.03%Q2 2026
16
PRINCIPAL FINANCIAL GROUP INC
CIK 0001126328
$233M874K0.11%Q2 2026
17
Polar Capital Holdings Plc
CIK 0001837309
$165M617K0.39%Q2 2026
18
GOLDMAN SACHS GROUP INC
CIK 0000886982
$149M560K0.01%Q2 2026
19
MORGAN STANLEY
CIK 0000895421
$145M544K0.01%Q2 2026
20
Invesco Ltd.
CIK 0000914208
$110M414K0.01%Q2 2026
Page 1 of 14
254 more holders available. Log in →